Skip to content

Evaluation of the effect of the black tea-derived aroma on automatic nervous system and cerebral blood flow in healthy adults.

Evaluation of the effect of the black tea-derived aroma on automatic nervous system and cerebral blood flow in healthy adults. - Evaluation of the effect of the black tea-derived aroma on automatic nervous system and cerebral blood flow in healthy adults.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000033569
Enrollment
7
Registered
2019-10-31
Start date
2018-08-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None (Healthy adults)

Interventions

inhalation of black tea flavor

Sponsors

Kirin Company, Limited
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Individuals aged from 20 to 65 years, when giving the informed consent. 2) Individuals giving the written informed consent.

Exclusion criteria

Exclusion criteria: 1) Individuals who declare the allergy symptoms against test diets. 2) Individuals who have anamnesis of cranial nerve disease. 3) Individuals who have anamnesis of the autonomic nervous system. 4) Individuals who have mental symptoms, or who have been diagnosed as mental disorder. 5) Individuals who are being treated with hormone, or who have been diagnosed as menopausal symptoms 6) Individuals who can't perform the study because it's olfactory impairment. 7) Individuals who regularly take drugs or health foods affecting cognitive functions 8) Individuals who regularly take drugs of health foods affecting autonomic nervous system. 9) Individuals who is not suitable for subjects by pre-test questionnaire. 10) Individuals who are planned to participate in other clinical study. 11) Individuals who are pregnant or breastfeeding during the study. 12) Individuals who sometimes have irregular lifestyles during the study. 13) Individuals who are judged as unsuitable for the study by the investigator for other reason.

Design outcomes

Primary

MeasureTime frame
Pupillary reaction to light Cerebral blood flow

Secondary

MeasureTime frame
Cognitive tasks Questionnaires

Countries

Japan

Contacts

Public ContactKeiko Kobayashi

Kirin Company, Limited Research and Development Division, Research Laboratories for Health Science & Food Technologies

keiko_kobayashi@kirin.co.jp080-2016-9331

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026